{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:00:43Z","timestamp":1791907243441,"version":"4.3.4"},"reference-count":35,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2025,2,9]],"date-time":"2025-02-09T00:00:00Z","timestamp":1739059200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: Hidradenitis suppurativa (HS) has been previously associated with greater rates of major adverse cardiac events (MACEs) compared to the general population. This study aims to better elucidate the association between HS, MACEs, and other cardiovascular diseases. Methods: We utilized TriNetX, a global database of electronic health records, to conduct a retrospective cohort study. HS patients were matched on demographic and cardiovascular disease risk factors to both healthy and psoriasis groups as controls. Results: After adjusting for cardiovascular disease risk factors, HS patients had a relative risk (RR) (95% CI) of 2.06 (1.83\u20132.32) for myocardial infarction, 1.62 (1.44\u20131.82) for ischemic stroke, 2.21 (2.04\u20132.40) for heart failure, 1.95 (1.84\u20132.07) for MACEs, and 2.57 (2.34\u20132.83) for all-cause mortality compared to healthy controls. When comparing HS patients to matched psoriasis controls, HS patients had an RR of 1.31 (1.17\u20131.47) for myocardial infarction, 1.04 (0.93\u20131.16) for ischemic stroke, 1.24 (1.15\u20131.34) for heart failure, 1.16 (1.09\u20131.22) for MACEs, and 1.38 (1.27\u20131.5) for all-cause mortality. Herein, we demonstrate that patients with HS have increased rates of all cardiovascular diseases investigated when compared to healthy and psoriasis controls, even after adjusting for cardiovascular disease risk factors. Conclusions: These findings highlight the potential benefit in screening for and managing modifiable cardiovascular risk factors in HS patients.<\/jats:p>","DOI":"10.3390\/jcm14041110","type":"journal-article","created":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T03:39:47Z","timestamp":1739158787000},"page":"1110","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Hidradenitis Suppurativa Is Associated with an Increased Risk of Adverse Cardiac Events and All-Cause Mortality"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-5378-9695","authenticated-orcid":false,"given":"Thomas Z.","family":"Rohan","sequence":"first","affiliation":[{"name":"Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA 19107, USA"},{"name":"Department of Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, PA 19107, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramsay","family":"Hafer","sequence":"additional","affiliation":[{"name":"Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA 19107, USA"},{"name":"Department of Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, PA 19107, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3023-6900","authenticated-orcid":false,"given":"Teresa","family":"Duong","sequence":"additional","affiliation":[{"name":"Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA 19107, USA"},{"name":"Department of Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, PA 19107, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rishob","family":"Dasgupta","sequence":"additional","affiliation":[{"name":"Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA 19107, USA"},{"name":"Department of Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, PA 19107, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9684-0627","authenticated-orcid":false,"given":"Sherry","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, PA 19107, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,2,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Vossen, A.R.J.V., van der Zee, H.H., and Prens, E.P. (2018). Hidradenitis suppurativa: A systematic review integrating inflammatory pathways into a cohesive pathogenic model. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.02965"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1111\/bjd.14075","article-title":"Dysregulated cytokine expression in lesional and nonlesional skin in hidradenitis suppurativa","volume":"173","author":"Kelly","year":"2015","journal-title":"Br. J. Dermatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"601","DOI":"10.2340\/00015555-0749","article-title":"Increased serum tumour necrosis factor-alpha in hidradenitis suppurativa patients: Is there a basis for treatment with anti-tumour necrosis factor-alpha agents?","volume":"89","author":"Matusiak","year":"2009","journal-title":"Acta Derm. Venereol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1111\/j.1365-2133.2011.10254.x","article-title":"Elevated levels of tumour necrosis factor (TNF)-\u03b1, interleukin (IL)-1\u03b2 and IL-10 in hidradenitis suppurativa skin: A rationale for targeting TNF-\u03b1 and IL-1\u03b2","volume":"164","author":"Broecke","year":"2011","journal-title":"Br. J. Dermatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s00403-015-1596-5","article-title":"Patients with hidradenitis suppurativa carry a higher systemic inflammatory load than other dermatological patients","volume":"307","author":"Riis","year":"2015","journal-title":"Arch. Dermatol. Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1161\/ATVBAHA.114.303284","article-title":"Small dense low-density lipoprotein-cholesterol concentrations predict risk for coronary heart disease: The Atherosclerosis Risk In Communities (ARIC) study","volume":"34","author":"Hoogeveen","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1016\/j.jacc.2020.02.059","article-title":"Triglyceride-Rich Lipoprotein Cholesterol, Small Dense LDL Cholesterol, and Incident Cardiovascular Disease","volume":"75","author":"Duran","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1365-2796.2010.02310.x","article-title":"Psoriasis is associated with clinically significant cardiovascular risk: A Danish nationwide cohort study","volume":"270","author":"Ahlehoff","year":"2011","journal-title":"J. Intern. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1136\/ard.2010.143396","article-title":"The risk of myocardial infarction in rheumatoid arthritis and diabetes mellitus: A Danish nationwide cohort study","volume":"70","author":"Lindhardsen","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/j.cgh.2018.04.031","article-title":"Increased risk of acute myocardial infarction and heart failure in patients with inflammatory bowel diseases","volume":"16","author":"Aniwan","year":"2018","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Proctor, M.J., McMillan, D.C., Horgan, P.G., Fletcher, C.D., Talwar, D., and Morrison, D.S. (2015). systemic inflammation predicts all-cause mortality: A glasgow inflammation outcome study. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0116206"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Sorriento, D., and Iaccarino, G. (2019). Inflammation and cardiovascular diseases: The most recent findings. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20163879"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Mehta, N.N., Shin, D.B., Joshi, A.A., Dey, A.K., Armstrong, A.W., Duffin, K.C., Fuxench, Z.C., Harrington, C.L., Hubbard, R.A., and Kalb, R.E. (2018). Effect of 2 Psoriasis Treatments on Vascular Inflammation and Novel Inflammatory Cardiovascular Biomarkers: A Randomized Placebo-Controlled Trial. Circ. Cardiovasc. Imaging, 11.","DOI":"10.1161\/CIRCIMAGING.117.007394"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/j.jacc.2021.02.009","article-title":"Cardiovascular risk in patients with psoriasis: JACC review topic of the week","volume":"77","author":"Garshick","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Radovanovic, M., Jankovic, J., Mandic-Rajcevic, S., Dumic, I., Hanna, R.D., and Nordstrom, C.W. (2023). Ideal Cardiovascular Health and Risk of Cardiovascular Events or Mortality: A Systematic Review and Meta-Analysis of Prospective Studies. J. Clin. Med., 12.","DOI":"10.3390\/jcm12134417"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1111\/bjd.13122","article-title":"Association of hidradenitis suppurativa disease severity with increased risk for systemic comorbidities","volume":"171","author":"Crowley","year":"2014","journal-title":"Br. J. Dermatol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/jdv.18044","article-title":"Psoriasis and metabolic syndrome: Implications for the management and treatment of psoriasis","volume":"36","author":"Wu","year":"2022","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/j.1365-2133.2008.08707.x","article-title":"Incidence of risk factors for myocardial infarction and other vascular diseases in patients with psoriasis","volume":"159","author":"Kaye","year":"2008","journal-title":"Br. J. Dermatol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00403-013-1437-3","article-title":"High prevalence of cardiovascular risk factors in patients with moderate or severe psoriasis in northern China","volume":"306","author":"Ma","year":"2014","journal-title":"Arch. Dermatol. Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1001\/jamadermatol.2015.6264","article-title":"Risk of Major Adverse Cardiovascular Events and All-Cause Mortality in Patients with Hidradenitis Suppurativa","volume":"152","author":"Egeberg","year":"2016","journal-title":"JAMA Dermatol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/1346-8138.15038","article-title":"Increased risk of cardiovascular comorbidities in hidradenitis suppurativa: A nationwide, population-based, cohort study in Taiwan","volume":"46","author":"Hung","year":"2019","journal-title":"J. Dermatol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jamadermatol.2019.3412","article-title":"Incidence of myocardial infarction and cerebrovascular accident in patients with hidradenitis suppurativa","volume":"156","author":"Reddy","year":"2020","journal-title":"JAMA Dermatol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/ijd.17186","article-title":"Risk of cardiovascular disorders in hidradenitis suppurativa patients: A large-scale, propensity-matched global retrospective cohort study","volume":"63","author":"Krajewski","year":"2024","journal-title":"Int. J. Dermatol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s00403-022-02369-5","article-title":"Hidradenitis suppurativa and the risk of myocardial infarction, cerebrovascular accident, and peripheral vascular disease: A population-based study","volume":"315","author":"Kridin","year":"2023","journal-title":"Arch. Dermatol. Res."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Jim\u00e9nez-Gallo, D., de la Varga-Mart\u00ednez, R., Ossorio-Garc\u00eda, L., Albarr\u00e1n-Planelles, C., Rodr\u00edguez, C., and Linares-Barrios, M. (2017). The Clinical Significance of Increased Serum Proinflammatory Cytokines, C-Reactive Protein, and Erythrocyte Sedimentation Rate in Patients with Hidradenitis Suppurativa. Mediat. Inflamm., 2017.","DOI":"10.1155\/2017\/2450401"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.jaad.2021.07.035","article-title":"The inflammatory proteome of hidradenitis suppurativa skin is more expansive than that of psoriasis vulgaris","volume":"86","author":"Navrazhina","year":"2022","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1111\/jdv.14076","article-title":"Assessment of subclinical atherosclerosis in hidradenitis suppurativa","volume":"31","author":"Pascual","year":"2017","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Teague, H., and Mehta, N.N. (2016). The link between inflammatory disorders and coronary heart disease: A look at recent studies and novel drugs in development. Curr. Atheroscler. Rep., 18.","DOI":"10.1007\/s11883-015-0557-y"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Ward, R., Kakaati, R., Liu, B., Green, C., and Jaleel, T. (2019). 9798\u2014Hidradenitis suppurativa is associated with increased odds of stroke, coronary artery disease, heart failure, and PAD: A population-based analysis in the United States. J. Am. Acad. Dermatol., 81.","DOI":"10.1016\/j.jaad.2019.06.047"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1001\/jamacardio.2016.1326","article-title":"Recent trends in cardiovascular mortality in the united states and public health goals","volume":"1","author":"Sidney","year":"2016","journal-title":"JAMA Cardiol."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Sterpetti, A.V., Gabriele, R., Iannone, I., Campagnol, M., Borrelli, V., Sapienza, P., and Dimarzo, L. (2024). Trends towards increase of Cardiovascular diseases mortality in USA: A comparison with Europe and the importance of preventive care. Curr. Probl. Cardiol., 49.","DOI":"10.1016\/j.cpcardiol.2024.102459"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Amini, M., Zayeri, F., and Salehi, M. (2021). Trend analysis of cardiovascular disease mortality, incidence, and mortality-to-incidence ratio: Results from global burden of disease study 2017. BMC Public Health, 21.","DOI":"10.1186\/s12889-021-10429-0"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.amepre.2023.11.009","article-title":"Trends in Cardiovascular Disease Mortality Rates and Excess Deaths, 2010\u20132022","volume":"66","author":"Woodruff","year":"2024","journal-title":"Am. J. Prev. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.jacc.2022.05.033","article-title":"Cardiovascular Disease Projections in the United States Based on the 2020 Census Estimates","volume":"80","author":"Mohebi","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s13524-015-0372-7","article-title":"Disease incidence and mortality among older Americans and Europeans","volume":"52","author":"Michaud","year":"2015","journal-title":"Demography"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/4\/1110\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:29:54Z","timestamp":1760027394000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/4\/1110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,9]]},"references-count":35,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,2]]}},"alternative-id":["jcm14041110"],"URL":"https:\/\/doi.org\/10.3390\/jcm14041110","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,9]]}}}